Quoin Pharmaceuticals Ltd. ADR Stock
The community is currently still undecided about Quoin Pharmaceuticals Ltd. ADR with 1 Buy predictions and 0 Sell predictions.
With a target price of 3 € there is potential for a 508.52% increase which would mean more than doubling the current price of 0.49 € for Quoin Pharmaceuticals Ltd. ADR.
Our community identified positive and negative aspects for Quoin Pharmaceuticals Ltd. ADR stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Quoin Pharmaceuticals Ltd. ADR stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Quoin Pharmaceuticals Ltd. ADR in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quoin Pharmaceuticals Ltd. ADR vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Quoin Pharmaceuticals Ltd. ADR | - | - | - | - | - | - | - |
Medpace Holdings Inc | -0.510% | -1.055% | -2.222% | 80.000% | 26.833% | 156.403% | - |
Galapagos N.V. | 1.570% | 2.146% | -6.273% | -33.557% | -30.616% | -57.549% | - |
Taro Pharmaceutical Industries Ltd | 1.030% | -0.508% | -0.508% | 12.000% | 4.255% | -32.991% | -52.479% |
Comments
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) had its price target lowered by analysts at Maxim Group from $15.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for QNRX provided by MarketBeat